Skip to main content
. 2018 Mar 21;50(2):303–316. doi: 10.4143/crt.2018.143

Table 9.

Crude and age-standardized rates of cancer prevalence by sex on January 1, 2016 in Korea

Site/Type Crude prevalence rate per 100,000a)
Age-standardized prevalence rate per 100,000b)
Both sexes Men Women Both sexes Men Women
All sites 3,162.8 2,781.0 3,544.1 1,956.9 1,826.6 2,171.5
Lip, oral cavity, and pharynx 42.8 57.6 28.1 26.8 37.9 17.2
Esophagus 18.0 32.5 3.6 10.3 20.6 1.8
Stomach 504.4 668.9 340.1 291.5 425.6 180.9
Colon and rectum 433.1 516.8 349.4 248.2 330.6 181.7
Liver 120.3 180.2 60.4 73.5 116.8 34.2
Gallbladderc) 38.2 39.1 37.3 21.1 24.7 18.4
Pancreas 18.7 19.8 17.6 11.1 12.9 9.7
Larynx 19.7 37.1 2.3 11.2 23.6 1.2
Lung 137.2 172.8 101.8 78.7 110.2 54.5
Breast 351.5 2.7 699.8 221.7 1.7 435.9
Cervix uteri 99.1 - 198.0 61.5 - 120.0
Corpus uteri 40.9 - 81.8 26.1 - 51.2
Ovary 35.5 - 71.0 24.2 - 48.1
Prostate 136.3 272.8 - 71.3 170.0 -
Testis 5.8 11.5 - 5.2 10.3 -
Kidney 69.3 93.7 45.0 43.5 62.0 27.1
Bladder 61.6 100.6 22.7 33.7 64.1 10.6
Brain and CNS 20.3 21.0 19.7 17.2 18.3 16.1
Thyroid 696.8 236.3 1,156.8 464.9 160.2 767.5
Hodgkin lymphoma 5.0 6.4 3.7 4.2 5.1 3.2
Non-Hodgkin lymphoma 53.9 61.4 46.5 38.2 45.9 31.1
Multiple myeloma 10.5 10.9 10.0 6.1 7.0 5.4
Leukemia 37.8 41.8 33.8 35.2 39.2 31.1
Other and ill defined 205.9 197.1 214.6 131.4 139.9 124.4

CNS, central nervous system.

a)

Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,

b)

Age-adjusted using the Segi’s world standard population,

c)

Includes the gallbladder and other/unspecified parts of the biliary tract.